U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07735104) titled 'Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of QLS2319 in Healthy Subjects and Cancer Cachexia' on July 22.
Brief Summary: Study To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of QLS2319 in Healthy Subjects and Cancer Cachexia
Study Start Date: Sept. 01
Study Type: INTERVENTIONAL
Condition:
Cancer Cachexia Syndrome
Cancer Cachexia
Intervention:
DRUG: QLS2319
QLS2319 will be administered via subcutaneous injection
DRUG: Placebo
placebo will be administered via subcutaneous injection
Recruitment Status: NOT_YET_RECRUITING
S...